Family history and genetic risk score combined to guide cancer risk stratification: A prospective cohort study
International Journal of Cancer · 01.02.2025 · 156 (3) · 505-517
DOI: 10.1002/ijc.35187 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift International Journal of Cancer, online erschienen am 18.09.2024. Verfasst von Chen Ji und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Neoplasms, Genetic Predisposition to Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Excellent Youth Foundation of Jiangsu Scientific Committee.
Abstract (Originalsprache)
Family history (FH) of cancer and polygenic risk scores (PRS) are pivotal for cancer risk assessment, yet their combined impact remains unclear. Participants in the UK Biobank (UKB) were recruited between 2006 and 2010, with complete follow‐up data updated until February 2020 for Scotland and January 2021 for England and Wales. Using UKB data ( N = 442,399), we constructed PRS and incidence‐weighted overall cancer PRS (CPRS). FH was assessed through self‐reported standardized questions. Among 202,801 men (34.6% with FH) and 239,598 women (42.0% with FH), Cox regression was used to examine the associations between FH, PRS, and cancer risk. We found a significant dose–response relationship between FH of cancer and corresponding cancer risk ( P trend < .05), with over 10 significant pairs of cross‐cancer effects of FH. FH and PRS are positively correlated and independent. Joint effects of FH of cancer (multiple cancers) and PRS (CPRS) on corresponding cancer risk were observed: for instance, compared with participants with no FH of cancer and low PRS, men with FH of cancer and high PRS had the highest risk of colorectal cancer (hazard ratio [HR]: 3.69, 95% confidence interval [CI]: 3.01–4.52). Additive interactions were observed in prostate and overall cancer risk for men and breast cancer for women, with the most significant result being a relative excess risk of interaction (RERI) of 2.98, accounting for ~34% of the prostate cancer risk. In conclusion, FH and PRS collectively contribute to cancer risk, supporting their combined application in personalized risk assessment and early intervention strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
- Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine and China International Cooperation Center for Environment and Human Health, Nanjing Medic…
- Department of Cancer Prevention, Zhejiang Cancer Hospital, Hangzhou, China.
- Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.
- Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
- Public Health Institute of Gusu School, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
ORCID-Profile: Lingbin Du, Guangfu Jin
Förderung
- National Natural Science Foundation of China
- Excellent Youth Foundation of Jiangsu Scientific Committee
Zitieren
APA
Ji, C., Ge, W., Zhu, C., Shen, F., Yu, Y., Pang, G., Li, Q., Zhu, M., Ma, Z., Zhu, X., Fu, Y., Gong, L., Wang, T., Du, L., Jin, G., & Zhu, M. (2025). Family history and genetic risk score combined to guide cancer risk stratification: A prospective cohort study. International Journal of Cancer, 156(3), 505-517. https://doi.org/10.1002/ijc.35187
Vancouver
Ji C, Ge W, Zhu C, Shen F, Yu Y, Pang G, et al. Family history and genetic risk score combined to guide cancer risk stratification: A prospective cohort study. International Journal of Cancer. 2025;156(3):505-517. doi:10.1002/ijc.35187
BibTeX
@article{Ji2025,
author = {Ji, Chen and Ge, Wenjing and Zhu, Chen and Shen, Fang and Yu, Yuhui and Pang, Guanlian and Li, Qiao and Zhu, Mingxuan and Ma, Zhimin and Zhu, Xia and Fu, Yating and Gong, Linnan and Wang, Tianpei and Du, Lingbin and Jin, Guangfu and Zhu, Meng},
title = {Family history and genetic risk score combined to guide cancer risk stratification: A prospective cohort study},
journal = {International Journal of Cancer},
year = {2025},
volume = {156},
number = {3},
pages = {505--517},
doi = {10.1002/ijc.35187}
}
EUVIMED